← Open Payments lookup

LUKE PERIS: Open Payments

NPI 1770613994 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$957 in 29 payments from 7 companies in 2025. Trend: 2023 $801 · 2024 $531 · 2025 $957

Food & beverage: $957
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$348
Axsome Therapeutics, Inc.6$241
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$122
Supernus Pharmaceuticals, Inc.6$121
Takeda Pharmaceuticals U.S.A., Inc.4$76
Corium, LLC1$25
Janssen Pharmaceuticals, Inc1$23

Products named: REXULTI, Auvelity, CAPLYTA, Qelbree, TRINTELLIX, Azstarys, SPRAVATO.

Industry payments across TX — which companies pay providers there.